Insider Title Company Date Price Return Shares Value
O'Gorman Cedric Chief Medical Officer RELMADA THERAPEUTICS, INC. (RLMD) 2023-05-23 $3.18 -23.9% 10,000 $31,800
Return Profit / (loss) Cost
Total -23.9% $-7,600 $31,800